DK677688D0 - Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne - Google Patents

Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne

Info

Publication number: DK677688D0
Authority: DK; Denmark
Prior art keywords: human; somatometricated; procedures; manufacturing; protein substances
Prior art date: 1987-04-06

Application number

DK677688A

Other languages

Danish (da)

English (en)

Other versions

DK677688A (da

Inventor

Emerald Martin Spencer

Original Assignee

Biogrowth Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-04-06

Filing date

1988-12-05

Publication date

1988-12-05

1988-12-05 Application filed by Biogrowth Inc filed Critical Biogrowth Inc

1988-12-05 Publication of DK677688A publication Critical patent/DK677688A/da

1988-12-05 Publication of DK677688D0 publication Critical patent/DK677688D0/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Zoology (AREA)
Biophysics (AREA)
Ophthalmology & Optometry (AREA)
Toxicology (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Emergency Medicine (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK677688A 1987-04-06 1988-12-05 Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne DK677688D0 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3488587A	1987-04-06	1987-04-06
PCT/US1988/001042 WO1988007863A1 (en)	1987-04-06	1988-03-31	Human somatomedin carrier protein subunits and process for producing them

Publications (2)

Publication Number	Publication Date
DK677688A DK677688A (da)	1988-12-05
DK677688D0 true DK677688D0 (da)	1988-12-05

Family

ID=21879212

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK677688A DK677688D0 (da)	1987-04-06	1988-12-05	Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne

Country Status (11)

Country	Link
EP (2)	EP0308500B1 (es)
JP (1)	JP2648951B2 (es)
AT (1)	ATE90690T1 (es)
AU (1)	AU627423B2 (es)
CA (1)	CA1340295C (es)
DE (1)	DE3881801T2 (es)
DK (1)	DK677688D0 (es)
ES (1)	ES2058341T3 (es)
IL (1)	IL85983A (es)
WO (1)	WO1988007863A1 (es)
ZA (1)	ZA882407B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5973115A (en) *	1987-05-15	1999-10-26	Amgen Inc.	Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) *	1988-03-22	1993-11-02	Genentech, Inc.	DNA encoding and methods of production of insulin-like growth factor binding protein BP53
EP0418230B1 (en) *	1988-04-12	1995-12-27	Amgen Boulder Inc.	Method for potentiating and inhibiting insulin-like growth factor activity
ATE125268T1 (de) *	1988-07-15	1995-08-15	Cent Sydney Area Health Serv	Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.
US5324820A (en) *	1988-07-15	1994-06-28	Central Sydney Area Health Service	Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US6465423B1 (en)	1988-07-15	2002-10-15	Central Sydney Area Health Service	Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5187151A (en) *	1991-02-12	1993-02-16	Genentech, Inc.	Use of binding protein with igf-i as an anabolic growth promoting agent
EP0800530A4 (en) *	1994-07-20	1998-12-02	Celtrix Pharma	IGF / IGFBP COMPLEX FOR PROMOTING BONE TRAINING AND REGULATING BONE REMODELING
US6121416A (en)	1997-04-04	2000-09-19	Genentech, Inc.	Insulin-like growth factor agonist molecules
US6420518B1 (en)	1997-04-04	2002-07-16	Genetech, Inc.	Insulin-like growth factor agonist molecules
AU762351B2 (en)	1999-01-06	2003-06-26	Genentech Inc.	Insulin-like growth factor (IGF) I mutant variants
IL143834A0 (en)	1999-01-06	2002-04-21	Genentech Inc	Insulin-like growth factor (igf) i mutant variants
ES2301547T3 (es)	2000-05-16	2008-07-01	Genentech, Inc.	Tratamiento de trastornos del cartilago.
AU2002248609B2 (en)	2001-03-14	2007-03-01	Genentech, Inc.	IGF antagonist peptides
ES2527871T3 (es)	2003-05-01	2015-02-02	Imclone Llc	Anticuerpos completamente humanos dirigidos contra el receptor del factor de crecimiento 1 similar a la insulina humana
NZ545940A (en)	2003-09-12	2009-12-24	Tercica Inc	Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
EP1670822A2 (en)	2003-10-03	2006-06-21	Genentech, Inc.	Igf binding proteins
DK2100614T3 (da)	2005-06-17	2013-10-28	Imclone Llc	Antistof mod PDGFR-alfa til anvendelse ved behandlingen af tumorer
WO2007092453A2 (en)	2006-02-03	2007-08-16	Imclone Systems Incorporated	Igf-ir antagonists as adjuvants for treatment of prostate cancer
PE20201166A1 (es)	2017-09-11	2020-10-28	Shire Human Genetic Therapies	Metodos y composiciones para tratar enfermedades pulmonares cronicas
KR20230113287A (ko)	2020-10-19	2023-07-28	오크 힐 바이오 리미티드	신생아에 사용하기에 적합한 조성물
MX2024008819A (es)	2022-01-19	2024-09-17	Oak Hill Bio Ltd	Composiciones y metodos para reducir la oxidacion de igf-1/igfbp.
WO2023242439A1 (en)	2022-06-17	2023-12-21	Oak Hill Bio Limited	Vascular stabilisation (preterm infants)
WO2023242440A1 (en)	2022-06-17	2023-12-21	Oak Hill Bio Limited	Treament of lungs in infants
WO2023242442A1 (en)	2022-06-17	2023-12-21	Oak Hill Bio Limited	Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2024170612A1 (en)	2023-02-14	2024-08-22	Oak Hill Bio Limited	Treatment of healing dysregulation in gi tissue

1988
- 1988-03-31 DE DE88904042T patent/DE3881801T2/de not_active Expired - Fee Related
- 1988-03-31 AT AT88904042T patent/ATE90690T1/de active
- 1988-03-31 JP JP63503623A patent/JP2648951B2/ja not_active Expired - Lifetime
- 1988-03-31 WO PCT/US1988/001042 patent/WO1988007863A1/en active IP Right Grant
- 1988-03-31 ES ES88904042T patent/ES2058341T3/es not_active Expired - Lifetime
- 1988-03-31 AU AU17020/88A patent/AU627423B2/en not_active Ceased
- 1988-03-31 EP EP88904042A patent/EP0308500B1/en not_active Expired - Lifetime
- 1988-04-05 CA CA000563309A patent/CA1340295C/en not_active Expired - Fee Related
- 1988-04-05 IL IL8598388A patent/IL85983A/en unknown
- 1988-04-06 EP EP88303041A patent/EP0294021A1/en active Pending
- 1988-04-07 ZA ZA882407A patent/ZA882407B/xx unknown
- 1988-12-05 DK DK677688A patent/DK677688D0/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL85983A0 (en)	1988-09-30
ZA882407B (en)	1988-09-28
JP2648951B2 (ja)	1997-09-03
AU1702088A (en)	1988-11-04
CA1340295C (en)	1998-12-29
EP0308500A1 (en)	1989-03-29
IL85983A (en)	1994-10-07
ATE90690T1 (de)	1993-07-15
DE3881801T2 (de)	1993-12-23
AU627423B2 (en)	1992-08-27
ES2058341T3 (es)	1994-11-01
EP0308500B1 (en)	1993-06-16
JPH01502986A (ja)	1989-10-12
DE3881801D1 (de)	1993-07-22
DK677688A (da)	1988-12-05
WO1988007863A1 (en)	1988-10-20
EP0294021A1 (en)	1988-12-07

Publication	Publication Date	Title
DK677688D0 (da)	1988-12-05	Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne
DK95291A (da)	1991-08-16	Rekombinante dna-molekyler
DK564989A (da)	1990-05-12	Bindingsproteiner
US5043429B1 (en)	1997-10-14	Protein fragments containing factor VIII binding domain of von willebrand factor
WO1994004691A3 (en)	1994-03-31	Dimer and multimer forms of single chain polypeptides
NZ224057A (en)	1991-04-26	A polypeptide of a vascular anticoagulant protein and method of preparation
DK0458841T3 (da)	1995-11-20	Fremgangsmåde til anvendelse og fremstilling af peptider
DK643087D0 (da)	1987-12-08	Fremgangsmaade til isomerisering af en kulbrintefoedestroem
DE69000338D1 (de)	1992-11-05	Expressionssystem zur herstellung von chimaeren monoklonalen antikoerpern.
FI97299C (fi)	1996-11-25	Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
FI953525A (fi)	1995-07-21	Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
ATE186781T1 (de)	1999-12-15	Verfahren zur herstellung von testelementen
NO930428D0 (no)	1993-02-08	Proteinstrukturen til plantetoksingelonin
HUT55800A (en)	1991-06-28	Process for producing anticoagulant peptides
AU576508B2 (en)	1988-09-01	Sythetic peptides antigenically corresponding to brain specific proteinoids
DE3881101D1 (de)	1993-06-24	Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper.

Legal Events

Date	Code	Title	Description
1994-11-21	AHB	Application shelved due to non-payment